The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 185-216

  Jiang, Hong ^a   Chess, Leonard ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

CD4; CD8; Immunoregulation; Qa 1; TCR

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CELL INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0034090207     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.185     Document Type: Review

References (188)

1. Mueller DL, Jenkins MK, Schwartz RH. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445
2. Janeway C Jr, Bottomly K. 1994. Signals and signs for lymphocyte responses. Cell 76:275
3. Lenschow DJ, Walunas TL, Bluestone JA. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233
4. Savage PA, Boniface JJ, Davis MM. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10:485
5. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y-h. 1998. Ligand recognition by aβ T cell receptors. Anna. Rev. Immunol. 16:523
6. Lenardo M, Chan K-M, Hornung F, McFarland H, Siegel R, Wang J, Zheng L. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221
7. +T cells that induces contact-dependent B cell differentiation (help). J Exp. Med. 175:1091
8. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. 1994. Activation of human dendritic cells through CD40 crosslinking. J. Exp. Med. 180:1263
9. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:5643
10. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406
11. + T cells. J. Exp. Med. 173:759
12. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. 1996. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev. 153:5
13. Jenkins MK. 1994. The ups and downs of T cell costimulation. Immunity 1:443
14. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406
15. + T-cell subsets: regulation of differentiation and function. Res. Immunol. 142:7
16. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348
17. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145
18. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29
19. + T cells. Annu. Rev. Immunol. 12:635
20. Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR. 1988. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239:181
21. Mor F, Cohen IR. 1993. Experimental aspects of T cell vaccination. Clin. Exp. Rheumatol. 11:555
22. + T cells in murine experimental allergic encephalomyelitis. Science 256:1213
23. + mice. Science 256:1210
24. Gaur A, Ruberti G, Haspel R, Mayer JP, Fathman CG. 1993. Requirement for CD8 + cells in T cell receptor peptideinduced clonal unresponsiveness. Science 259:91. Erratum. 1993. Science 260(5106):281
25. + T cells expressing V-β8 TCR: a role of the Qa-1 molecule. Immunity 2:185
26. Sun D, Whitaker JN, Wilson DB. 1999. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease. Int. Immunol. 11:307
27. Sun D, Whitaker JN, Wilson DB. 1999. Regulatory T cells in experimental allergic encephalomyelitis. III. Comparison of disease resistance in Lewis and Fischer 344 rats. Ear. J. Immunol. 29: 1101
28. Bloom BR, Modlin RL, Salgame P. 1992. Stigma variations: observations on suppressor T cells and leprosy. Annu. Rev. Immunol. 10:453
29. Formby B, Shao T. 1993. T cell vaccination against autoimmune diabetes in nonobese diabetic mice. Ann. Clin. Lab. Sci. 23:137
30. Lohse AW, Spahn TW, Wolfel T, Herkel J, Cohen IR, Meyer-zum-Buschenfelde KH. 1993. Induction of the antiergotypic response. Int. Immunol. 5:533
31. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H. 1988. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332:843
32. Kumar V, Sercarz E. 1993. T cell regulatory circuitry: antigen-specific and TCR-idiopeptide-specific T cell interactions in EAE. Int. Rev. Immunol. 9:287
33. Jiang H, Kashleva H, Xu LX, Forman J, Flaherty L, Pernis B, Braunstein NS, Chess L. 1998. T cell vaccination induces T cell receptor V-beta-specific Qa-I-restricted regulatory CD8( + ) T cells. Proc. Natl. Acad. Sci. USA 95:4533
34. Jerne NK. 1975. Immune system. Harvey Lecture - Web of V-domains. 1976:93
35. Weinberger JZ, Germain RN, Ju ST, Greene MI, Benacerraf B, Dorf ME. 1979. Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells. J. Exp. Med. 150:761
36. Dietz MH, Sy MS, Benacerraf B, Nisonoff A, Greene MI, Germain RN. 1981. Antigen-and receptor-driven regulatory mechanisms. VII. H-2-restricted antiidiotypic suppressor factor from efferent suppressor T cells. J. Exp. Med. 153:450
37. Green DR, Flood PM, Gershon RK. 1983. Immunoregulatory T-cell pathways. Annu. Rev. Immunol. 1:439
38. Ehrlich P. 1900. The Croonian Lecture: on immunity. Proc. R. Soc. London 66:424
39. Jerne NK. 1955. The natural selection theory of antibody formation. Proc. Natl. Acad. Soc. USA 41:849
40. Burnet FM. 1957. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20:67
41. Gowans JL, Gesner BM, McGregor DD. 1961. The immulogic activities of lymphocytes. In Ciba Found. Study Group, ed. G Wolstenhome, M O'Connor, p. 32. London: Churchill
42. NacKean LD, Zak SJ, Varco RL, Godd RA. 1956. The role of the thymus in antibody production: an experimental study of immune response in the thymectomized rabbit. Transplant. Bull. 4:21
43. Glick B, Chang TS, Jaap RG. 1956. The bursa of Fabricius and antibody production. Poultry Sci. 35:224
44. Cooper MD, Raymond DA, Peterson RD, South MA, Good RA. 1966. The functions of the thymus system and the bursa system in the chicken. J. Exp. Med. 123:75
45. Dent PB, Good RA. 1965. Absence of antibody production in the bursa of Fabricius. Nature 207:491
46. Miller JF, Mitchell GF. 1967. The thymus and the precursors of antigen reactive cells. Nature 216:659
47. Claman HN, Chaperon EA, Triplett RF, 1966. Thymus-marrow cell combinations - synergism in antyibody formation. Proc. Soc. Exp. Biol. Med. 122:1167
48. Miller JF, Mitchell GF. 1968. Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J. Exp. Med. 128:801
49. Mitchell GF, Miller JF. 1968. Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J. Exp. Med. 128:821
50. Nossal GJ, Cunningham A, Mitchell GF, Miller JF. 1968. Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J. Exp. Med. 128:839
51. Gershon RK, Kondo K. 1970. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18:723
52. Gershon RK, Kondo K. 1971. Infectious immunological tolerance. Immunology 21:903
53. Gershon RK. 1974. T cell control of antibody production. Contemp. Top. Immunobiol. 3:1
54. Gershon RK. 1975. A disquisition on suppressor T cells. Transplant. Rev. 26:170
55. Gershon RK. 1976. The role of suppression in immunoregulation. Adv. Exp. Med. Biol. 66:557
56. Gershon RK, Mokyr MB, Mitchell MS. 1974. Activation of suppressor T cells by tumour cells and specific antibody. Nature 250:594
57. Askenase PW, Hayden BJ, Gershon RK. 1975. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J. Exp. Med. 141:697
58. + cells in the generation of killer activity. J. Exp. Med. 141:1390
59. Cantor H, Boyse EA. 1975. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J. Exp. Med. 141:1376
60. Jandinski J, Cantor H, Tadakuma T, Peavy DL, Pierce CW. 1976. Separation of helper T cells from suppressor T cells expressing different Ly components. I. Polyclonal activation: suppressor and helper activities are inherent properties of distinct T-cell subclasses. J. Exp. Med. 143:1382
61. Cantor H, Shen FW, Boyse EA. 1976. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J. Exp. Med. 143:1391
62. Chess L, Schlossman SF. 1977. Human lymphocyte subpopulations. Adv. Immunol. 25:213
63. Evans RL, Breard JM, Lazarus H, Schlossman SF, Chess L. 1977. Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens. J. Exp. Med. 145:221
64. Kung P, Goldstein G, Reinherz EL, Schlossman SF. 1979. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206:347
65. Reinherz EL, Schlossman SF. 1980. The differentiation and function of human T lymphocytes. Cell 19:821
66. Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch FW. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immu-nol. 131:2445
67. Swain SL, Dialynas DP, Fitch FW, English M. 1984. Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J. Immunol. 132:1118
68. Rao A, Allard WJ, Hogan PG, Rosenson RS, Cantor H. 1983. Alloreactive T-cell clones. Ly phenotypes predict both function and specificity for major histocompatibility complex products, Immu-nogenetics 17:147
69. Thomas Y, Rogozinski L, Chess L. 1983. Relationship between human T cell functional heterogeneity and human T cell surface molecules. Immunol. Rev. 74:113
70. Cantor H, Hugenberger J, McVay-Boudreau L, Eardley DD, Kemp J, Shen FW, Gershon RK. 1978. Immunoregulatory circuits among T-cell sets. Identification of a subpopulation of T-helper cells that induces feedback inhibition. J. Exp. Med. 148:871
71. Cantor H, McVay-Boudreau L, Hugenberger J, Naidorf K, Shen FW, Gershon RK. 1978. Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J. Exp. Med. 147:1116
72. Eardley DD, Hugenberger J, McVay-Boudreau L, Shen FW, Gershon RK, Cantor H. 1978. Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J. Exp. Med. 147:1106
73. Dorf ME, Benacerraf B. 1984. Suppressor cells and immunoregulation. Annu. Rev. Immunol. 2:127
74. Germain RN, Benacerraf B. 1980. Helper and suppressor T cell factors. Springer Semin. Immunopathol. 3:93
75. Benacerraf B, Greene MI, Sy MS, Dorf ME. 1982. Suppressor T cell circuits. Ann. NYAcad. Sci. 392:300
76. Asherson GL, Colizzi V, Zembala M. 1986. An overview of T-suppressor cell circuits. Annu. Rev. Immunol. 4:37
77. Pierres M, Germain RN, Dorf ME, Benacerraf B. 1978. In vivo effects of antila alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants. J. Exp. Med. 147:656
78. Eardley DD, Murphy DB, Kemp JD, Shen FW, Cantor H, Gershon RK. 1980. Ly-1 inducer and Ly-1,2 acceptor T cells in the feedback suppression circuit bear an I-J-subregion controlled determinant. Immunogenetics 11:549
79. Green DR, Eardley DD, Kimura A, Murphy DB, Yamauchi K, Gershon RK. 1981. Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: characterization of an effector cell in the contrasuppressor circuit. Eur. J. Immunol. 11:973
80. Yamauchi K, Taniguchi M, Green D, Gershon RK. 1982. The use of a monoclonal i-j-specific antibody to distinguish cells in the feedback suppression circuit from those in the contrasuppressor circuit. Immunogenetics 16:551
81. Stanton TH, Calkins CE, Jandinski J, Schendel DJ, Stutman O, Cantor H, Boyse EA. 1978. The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions. J. Exp. Med. 148:963
82. Kronenberg M, Steinmetz M, Kobori J, Kraig E, Kapp JA, Pierce CW, Sorensen CM, Suzuki G, Tada T, Hood L. 1983. RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subrogions of the murine major histocompatibility complex. Proc. Natl. Acad. Sci. USA 80:5704
83. Steinmetz M, Minard K, Horvath S, McNicholas J, Srelinger J, Wake C, Long E, Mach B, Hood L. 1982. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 300:35
84. Stanton TH, Boyse EA. 1979. A new serologically defined locus, Qa-1, in the Tla-region of the mouse. Immunogenetics 3:525
85. Kastner DL, Rich RR, Chu L. 1979. Qa1-associated antigens. II. Evidence for functional differentiation from H-2K and H-2D antigens. J. Immunol. 123:1239
86. Lalanne JL, Transy C, Guerin S, Darche S, Meulien P, Kourilsky P. 1985. Expression of class I genes in the major histocompatibility complex: identification of eight distinct mRNAs in DBA/2 mouse liver. Cell 41:469
87. Connolly DJ, Cotterill LA, Hederer RA, Thorpe CJ, Travers PJ, McVey JH, Dyson J, Robinson PJ. 1993. A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J. Immunol. 151:6089
88. Shawar SM, Vyas JM, Rodgers JR, Rich RR. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839
89. Moller G. 1988. Do suppressor T cells exist? Scand, J. Immunol. 27:247
90. Janeway CA Jr. 1988. Do suppressor T cells exist? A reply [editorial]. Scand. J. Immunol. 27:621
91. Bloom BR, Salgame P, Diamond B. 1992. Revisiting and revising suppressor T cells. Immunol. Today 13:131
92. Anderson LC, Binz H, Wigzell H. 1976. Specific unresponsiveness to transplantation antigens induced by autoimmunisation with syngeneic, antigenspecific T lymphoblasts. Nature 264:778
93. Binz H, Wigzell H. 1976. Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigenbinding receptors. J. Exp. Med. 144:1438
94. Bellgrau D, Wilson DB. 1978. Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells. J. Exp. Med. 148:103
95. Bellgrau D, Wilson DB. 1979. Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T-cell receptors specific for major histocompatibility complex alloantigens. J. Exp. Med. 149:234
96. Kimura H, Pickard A, Wilson DB. 1984. Analysis of T cell populations that induce and mediate specific resistance to graft-versus-host disease in rats. J. Exp. Med. 160:652
97. Ben-Nun A, Wekerle H, Cohen IR. 1981. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292:60
98. Cohen IR, Weiner HL. 1988. T-cell vaccination. Immunol. Today 9:332
99. Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR. 1983. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219:56
100. Maron R, Zerubavel R, Friedman A, Cohen IR. 1983. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J. Immunol. 131:2316
101. Kakimoto K, Katsuki M, Hirofuji T, Iwata H, Koga T. 1988. Isolation of T cell line capable of protecting mice against collegen-induced arthritis. J. Immunol. 140:78
102. Elias D, Reshef T, Birk OS, van der Zee R, Walker MD, Cohen IR. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88:3088
103. van Laar JM, de Vries RR, Breedveld FC. 1993. T cell vaccination in humans: the experience in rheumatoid arthritis. Clin. Exp. Rheumatol. 11:S59
104. Zhang J, Medaer R, Stinissen P, Hafler D, Raus J. 1993. MHC-restricted depletion of human myelin basic proteinreactive T cells by T cell vaccination. Science 261:1451
105. Hafler DA, Cohen I, Benjamin DS, Weiner HL. 1992. T cell vaccination in multiple sclerosis: a preliminary report. Clin. Immunol. Immunopathol. 62:307
106. Mor F, Cohen IR. 1995. Vaccines to prevent and treat autoimmune diseases. Int. Arch. Allergy Immunol. 108:345
107. + T cells. In preparation
108. Nanda NK, Sercarz E. 1996. A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant. J. Exp. Med. 184:1037
109. Zamvil S, Nelson P, Trotter J, Mitchell D, Knobler R, Fritz R, Steinman L. 1985. T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317:355
110. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577
111. Vandenbark AA, Hashim G, Offner H. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541
112. Offner H, Hashim GA, Vandenbark AA. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430
113. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668. Erratum. 1990. Science 247(4947): 1167
114. Vandenbark AA, Hashim GA, Offner H. 1996. T cell receptor peptides in treatment of autoimmune disease: rationale and potential. J. Neurosci. Res. 43:391
115. Gold DP, Smith RA, Golding AB, Morgan EE, Dafashy T, Nelson J, Smith L, Diveley J, Laxer JA, Richieri SP, Carlo DJ, Brostoff SW, Wilsonc DB. 1997. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. J. Neuroimmunol. 76:29
116. Bourdette DN, Chou YK, Whitham RH, Buckner J, Kwon HJ, Nepom GT, Buenafe A, Cooper SA, Allegretta M, Hashim GA, Offner H, Vandenbark AA. 1998. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. J. Immunol. 161:1034
117. Vandenbark AA, Chou YK, Whitham R, Bourdette DN, Offner H. 1998. Effects of vaccination with T cell receptor peptides: epitope switching to a possible disease-protective determinant of myelin basic protein that is cross-reactive with a TCR BV peptide. Immunol. Cell Biol. 76:83
118. Gonzalo JA, Baixeras E, Gonzalez-Garcia A, George-Chandy A, Van-Rooijen N, Martinez C, Kroemer G. 1994. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion. J. Immunol. 152:1597
119. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B [see comments]. Nature 349:245
120. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091
121. Takahashi S, Maecker HT, Levy R. 1989. DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line. Eur. J. Immunol 19:1911
122. Lenardo MJ. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858
123. Boehme SA, Lenardo MJ. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23:1552
124. Stallcup KC, Springer TA, Mescher MF. 1981. Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. J. Immunol. 127:923
125. Bouwer HGA, Seaman MS, Forman J, Hinrichs DJ. 1997. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricing element for Listeria-specific CTLs. J. Immunol. 159:2795
126. Aldrich CJ, DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79:649
127. + T cells. Submitted
128. Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksenberg JA, Brocke S, Mor F, Cohen IR, Steinman L. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899
129. Lamb JR, Feldmann M. 1982. A human suppressor T cell clone which recognizes an autologous helper T cell clone. Nature 300:456
130. Naor D, Essery G, Tarcic N, Kahan M, Feldmann M. 1991. Regulatory interactions among autologous T cell clones. Human bifunctional T cell clones regulate the activity of an autologous T cell clone. Ann. NY Acad. Sci. 636:135
131. Naor D, Essery G, Tarcic N, Kahan M, Feldmann M. 1991. Human bifunctional T cell clones regulate the activity of an autologous T cell clone, Ann. NY Acad. Sci. 636:135
132. + cytotoxic and suppressor T cell clones. J. Immunol. 144:32
133. + T cells. Immunity 2:177
134. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909
135. Kumar V, Tabibiazar R, Geysen HM, Sercarz EE. 1995. Immunodominant framework region 3 peptide from TCR Vβ8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154:1941
136. Kumar V, Stellrecht K, Sercarz EE. 1996. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 184:1609
137. Kumar V, Coulsell E, Ober B, Hubbard G, Sercarz E, Ward ES. 1997. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159:5150
138. Kumar V, Sercarz E. 1996. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J Neurosci. Res. 45:334
139. Schoenberger SP, Toes REM, van der Voort EI, Offringa R, Melief CJM. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480
140. + T-helper and a T-killer cell. Nature 393:474
141. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478
142. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399
143. Lafaille JJ. 1998. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9:139
144. Van de Keere F, Tonegawa S. 1998. CD4( + ) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 188:1875
145. + T cells. J. Exp. Med. 183:2669
146. + suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis. J. Immunol. 143:3492
147. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J. Immunol. 146:1163
148. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737
149. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237
150. Zhang J, Raus J. 1995. Clonal depletion of human myelin basic protein-reactive T-cells by T-cell vaccination. Ann. NY Acad. Sci. 756:323
151. + T cells is receptor dependent and HLA-DQ restricted. Proc. Natl. Acad. Sci. USA 88:2598
152. Young JW, Steinman RM. 1996. The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation. Stem Cells 14:376
153. Thomas R, Davis LS, Lipsky PE. 1994. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J. Immunol. 152:2613
154. Tewarson S, Zaleska-Rutczynska Z, Figueroa F, Klein J. 1983. Polymorphism of Qa and Tla loci of the mouse. Tissue Antigens 22:204
155. Landolfi NF, Rich RR, Cook RG. 1985. The Qa-1 alloantigens. III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic products. J. Immunol. 135:1264
156. Aldrich CJ, Rodgers JR, Rich RR. 1988. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm. Immunogenetics 28:334
157. Aldrich CJ, Waltrip R, Hermel E, Attaya M, Lindahl KF, Monaco JJ, Forman J. 1992. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J. Immunol. 149:3773
158. Lowen LC, Aldrich CJ, Forman J. 1993. Analysis of T cell receptors specific for recognition of class IB antigens. J. Immunol. 151:6155
159. Kurepa Z, Hasemann CA, Forman J. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188: 973
160. Cotterill LA, Stauss HJ, Millrain MM, Pappin DJ, Rahman D, Canas B, Chandler P, Stackpoole A, Simpson E, Robinson PJ, Dyson PJ. 1997. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27:2123
161. Imani F, Soloski MJ. 1991. Heat shock proteins can regulate expression of the TIa region-encoded class Ib molecule Qa-1. Proc. Natl. Acad. Sci USA 88: 10475
162. Chun T, Aldrich CJ, Baldeon ME, Kawczynski LV, Soloski MJ, Gaskins HR. 1998. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology 94:64
163. Bouwer HG, Bai A, Forman J, Gregory SH, Wing EJ, Barry RA, Hinrichs DJ. 1998. Listeria monocytogenes-infected hepatocytes are targets of major histo-compatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect. Immun. 66:2814
164. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:5398
165. Seaman MS, Perarnau B, Lindahl KF, Lemonnier FA, Forman J. 1999. Response to Listeria monocytogertes in mice lacking MHC class Ia molecules. J. Immunol. 162:5429
166. Phillips JH, Chang CW, Mattson J, Gumperz JE, Parham P, Lanier LL. 1996. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5:163
167. Chang CW, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. 1995. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 25:2433
168. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. 1996. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J.. Immunol. 157:4741
169. Plougastel B, Trowsdale J. 1997. Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes. Eur. J. Immunol. 27:2835
170. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. 1998. Mouse CD94/ NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188:1841
171. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young N, Bell JI, Phillips JH, Lanier LL, McMichael AJ. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795
172. Salcedo M, Bousso P, Ljunggren HG, Kourilsky P, Abastado JP. 1998. The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur. J. Immunol. 28:4356
173. Sivakumar PV, Gunturi A, Salcedo M, Schatzle JD, Lai WC, Kurepa Z, Pitcher L, Seaman MS, Lemonnier FA, Bennett M, Forman J, Kumar V. 1999. Cutting edge: expression of functional CD94/ NKG2A inhibitory receptors on fetal NK1.1 + Ly-49-cells: a possible mechanism of tolerance during NK cell development. J. Immunol. 162:6976
174. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703
175. Lanier LL, Corliss B, Wu J, Phillips JH. 1998. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693
176. Lanier LL. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359
177. Lopez-Botet M, Bell T. 1999. Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol. 11:301
178. Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L, Lopez-Botet M, Fournie JJ, Gougeon ML. 1997. CD94/ NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J.. Immunol. 159:6009
179. Noppen C, Schaefer C, Zajac P, Schutz A, Kocher T, Kloth J, Heberer M, Colonna M, De Libero G, Spagnoli GC. 1998. C-type lectin-Hke receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur. J. Immunol. 28:1134
180. Bertone S, Schiavetti F, Bellomo R, Vitale C, Ponte M, Moretta L, Mingari MC. 1999. Transforming growth factor-beta-induced expression of CD94/ NKG2A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 29:23
181. Galiani MD, Aguado E, Tarazona R, Romero P, Molina I, Santamaria M, Solana R, Pena J. 1999. Expression of killer inhibitory receptors on cytotoxic cells from HTV-1-infected individuals. Clin. Exp. Immunol. 115:472
182. Speiser DE, Valmori D, Rimoldi D, Pittet MJ, Lienard D, Cerundolo V, MacDonald HR, Cerottini JC, Romero P. 1999. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur. J. Immunol. 29:1990
183. + T cell clone upon the aggregation of an activatory CD94/ kp39 heterodimer. J. Immunol. 162:3996
184. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. 1993. Dominance and crypticity of T cell antigenie determinants. Anna. Rev. Immunol. 11:729
185. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155
186. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14:203
187. Busch DH, Pamer EG. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701
188. Busch DH, Pilip I, Pamer EG. 1998. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J. Exp. Med. 188:61